This book examines the often tough questions raised by infectious diseases through essays that explore a host of legal and ethical issues. The authors also offer potential solutions in order to ensure that past errors are not repeated in response to future outbreaks. The essays touch on a number of key themes, including institutional competence, the accountability and responsibility of non-state actors, the importance of pharmaceuticals, and the move towards a rights-based approach in global health. Readers gain insights into such important questions as follows: How can we help victims in other countries? What (if any) responsibility should be placed upon international organizations whose actions exacerbate infectious diseases? How can we ensure that pharmaceutical research helps all communities, even those who cannot afford to pay for the products? While broadly covering global health law, the book adopts an inter-disciplinary approach that draws on public international law, philosophy, international relations, human rights law, and healthcare economics. As such, it is a valuable resource for academic libraries, appealing to scholars and postgraduates engaged in relevant research, as well as to those engaged with global health and policy at the international level.

Amid a global health crisis, the process for declaring a Public Health Emergency of International Concern (PHEIC) is at a crossroads. As a formal declaration by the World Health Organization, a PHEIC is governed by clear legislation as to what is, and what is not, deemed a global health security threat. However, it has become increasingly politicized, and the legal criteria now appear to be secondary to the political motivation or outcome of the announcement. Addressing multiple empirical case studies, including COVID-19, this multidisciplinary book explores the relationship between international law and international relations to interrogate how a PHEIC is declared and its role in how we collectively respond to outbreaks.

This book examines the often tough questions raised by infectious diseases through essays that explore a host of legal and ethical issues. The authors also offer potential solutions in order to ensure that past errors are not repeated in response to future outbreaks. The essays touch on a number of key themes, including institutional competence, the accountability and responsibility of non-state actors, the importance of pharmaceuticals, and the move towards a rights-based approach in global health. Readers gain insights into such important questions as follows: How can we help victims in other countries? What (if any) responsibility should be placed upon international organizations whose actions exacerbate infectious diseases? How can we ensure that pharmaceutical research helps all communities, even those who cannot afford to pay for the products? While broadly covering global health law, the book adopts an inter-disciplinary approach that draws on public international law, philosophy, international relations, human rights law, and healthcare economics. As such, it is a valuable resource for academic libraries, appealing to scholars and postgraduates engaged in relevant research, as well as to those engaged with global health and policy at the international level.